Abstract
Non-alcoholic fatty liver disease (NAFLD) stands as the leading cause of liver disorders worldwide, affecting approximately 25% of the population. It encompasses a spectrum ranging from simple steatosis to non-alcoholic steatohepatitis (NASH), a more severe form. The progression from steatosis to NASH involves lipotoxicity, oxidative stress, and inflammation. Recently, we investigated kin…